Rafarma Pharmaceuticals Inc. has published an amendment to their management certification for the year ending December 31, 2024. The document, originally issued on May 13, 2025, has been restated to include a required list of officers. It is important to note that this amendment was automatically generated by OTC Markets Group based on Rafarma's provided information, and OTC Markets Group disclaims any responsibility for the content of this restatement. The restated document does not specifically indicate whether the financial results themselves have been audited, and it primarily focuses on administrative updates and compliance.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。